Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
Meeting ReportMolecular Targeting Probes Track

monitoring the immune cell infiltration in the LPS-induced neuroinflammation region with simultaneous small animal PET/MR imaging using a TSPO-targeting probe

Kyungmin Kim, Juri Na, Ha Kim, Min Sun Lee, Guen Bae Ko, Kyeong Yun Kim, Byung Seok Moon, Sang Eun Kim, Keon Wook Kang, June-Key Chung, Byung Chul Lee, Jae Sung Lee and Hyewon Youn
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 549;
Kyungmin Kim
4Seoul National University Cancer Research Institut Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juri Na
2Seoul National University Seoul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ha Kim
4Seoul National University Cancer Research Institut Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Sun Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guen Bae Ko
7Seoul National University Hospital Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyeong Yun Kim
2Seoul National University Seoul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byung Seok Moon
3Seoul National University Bundang Hospital Seongnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sang Eun Kim
5Seoul National University College of Medicine Seongnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keon Wook Kang
8SEOUL NATIONAL UNIVERSITY HOSPITAL Seoul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June-Key Chung
6Seoul National University Hospital Chongro-Gu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byung Chul Lee
3Seoul National University Bundang Hospital Seongnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jae Sung Lee
1Seoul National University Chongno-Gu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyewon Youn
2Seoul National University Seoul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

549

Objectives: Recently, activated immune cell infiltration has been reported to involve in neuronal damages. Trafficking adoptive-transferred immune cells may provide valuable information to understand of various neuroinflammatory diseases. Here, we asked whether acute brain regional inflammation have any potential to recruit adoptively transferred splenocytes using simultaneous small animal PET/MR.

Methods: Lipopolysaccharide (LPS) was used to induce regional inflammation in the right striatum of a mouse brain (anteroposterior, +1.8; mediolateral, +2.0; dorsoventral,-3.0) using a Hamilton syringe at a rate of 0.25 ul/ min using a robotic stereotacxic device (Stoelting, IL, USA). Saline was used as a control treatment. Splenocytes (2 x 107) were isolated from luciferase expressing transgenic mice (B6.LucTg), and adoptively transferred to recipient B6 (C57BL/6) mouse by intravenously injection for visualizing immune cell localization with bioluminescence imaging. To evaluate the inflammation, simultaneous PET/MR scans were acquired using simultaneous small animal PET insert combined with 1T MRI (SimPET, Aspect imaging, Israel). 18F-CB251 probewas used to detect the 18-kDa translocator protein (TSPO, a marker for activated immune cells in the inflammatory region) activity at a dose ranging from 9.25 to 11.1 MBq per mouse. In vitro uptake assay was also performed for confirming the correlation between TSPO expression level and uptake of 18F-CB251 probe.

Results: Uptake experiments of 18F-CB251 probe were measured in the cells with differential TSPO expression such as TSPO-overexpressed 293FT cells and activated-macrophage Raw 264.7 cells. Higher uptake of 18F-CB251 was found in cells with higher TSPO expression. PET signals from 18F-CB251 showed 2.58 times (n=5) higher uptake in right striatum (LPS injection site) than in left striatum. MR scan, which is taken simultaneously, also showed slightly increased T2-weigthed signals in the right striatum of LPS-induced inflammatory region. On the other hand, saline injected mouse showed no significant difference (1.14 times) between the right striatum and left striatum. In addition, luciferase-expressing splenocytes were localized at the LPS-treated site in right striatum of mouse brain. Though BLI signals in LPS-treated region were 5.02 times (n=5) higher than that of saline-treated region after skin removal, 18F-CB251 PET signals generate more quantitative and non-invasive images for whole body scan.

Conclusion: We successfully visualized adoptively-transferred immune cell recruitment in the inflammatory region of brain using three different imaging modalities. Simultaneous scanning from simultaneous small animal PET/MR provides more accurate spatiotemporal information of immune cell localization in the neuro-inflammation site.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
monitoring the immune cell infiltration in the LPS-induced neuroinflammation region with simultaneous small animal PET/MR imaging using a TSPO-targeting probe
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
monitoring the immune cell infiltration in the LPS-induced neuroinflammation region with simultaneous small animal PET/MR imaging using a TSPO-targeting probe
Kyungmin Kim, Juri Na, Ha Kim, Min Sun Lee, Guen Bae Ko, Kyeong Yun Kim, Byung Seok Moon, Sang Eun Kim, Keon Wook Kang, June-Key Chung, Byung Chul Lee, Jae Sung Lee, Hyewon Youn
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 549;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
monitoring the immune cell infiltration in the LPS-induced neuroinflammation region with simultaneous small animal PET/MR imaging using a TSPO-targeting probe
Kyungmin Kim, Juri Na, Ha Kim, Min Sun Lee, Guen Bae Ko, Kyeong Yun Kim, Byung Seok Moon, Sang Eun Kim, Keon Wook Kang, June-Key Chung, Byung Chul Lee, Jae Sung Lee, Hyewon Youn
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 549;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Probes for Neuroimaging

  • A promising I-123 labeled radioligand for imaging neuroinflammation response by assessment P2X7 receptor expression
  • Discovery of a New Class of mGluR2 Selective Group II mGluR NAM PET Tracer
  • Exploration of new S1PR2 ligands and initial evaluation of a potent C-11 PET tracer in rodent
Show more Probes for Neuroimaging

Similar Articles

SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire